Transfection of siRNAs targeting ZMAT3 was performed in MDA-MB-231 and MCF-7 cells to investigate the regulatory role of ZMAT3 expression in breast cancer cell progression (Figures 12C, D).Western blot confirmed that ZMAT3 was successfully knocked down (Figure 12E). This evidence concerns the gene ZMAT3 and breast carcinoma.